all report title image
Ingographics Image

Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Restraints of the Global Infectious Disease Diagnostics Market

Factors such as high costs of molecular diagnostic tests, and lack of reimbursement is expected to restrain growth of the market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Infectious Disease Diagnostics Market, By Technique:
    • ELISA
    • Polymerase Chain Reaction
    • Immunoassays
    • Cell Cultures
    • Others
  • Global Infectious Disease Diagnostics Market, By Disease Indication:
    • CNS Infection
      • Meningitis
      • Brain Abscess
    • Diarrheal Disease
      • Shigellosis
      • Cholera
      • Enteric/Typhoid Fever
    • Respiratory Infections
      • Tuberculosis
      • Influenza
      • Bronchitis
    • Blood Infections
      • Malaria
      • Dengue
      • Infectious Mononucleosis
      • Others
    • STDs
      • Chlamydia
      • AIDS
      • Syphilis
      • Others
  • Global Infectious Disease Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Centers
    • Clinics
    • Government Organizations
  • Global Infectious Disease Diagnostics Market, By Geography:
    • North America
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technique
        • ELISA
        • Polymerase Chain Reaction
        • Immunoassays
        • Cell Cultures
        • Others
      • By Disease Indication
        • CNS Infection
          • Meningitis
          • Brain Abscess
        • Diarrheal Disease
          • Shigellosis
          • Cholera
          • Enteric/Typhoid Fever
        • Respiratory Infections
          • Tuberculosis
          • Influenza
          • Bronchitis
        • Blood Infections
          • Malaria
          • Dengue
          • Infectious Mononucleosis
          • Others
        • STDs
          • Chlamydia
          • AIDS
          • Syphilis
        • Others
      • By End User
        • Hospitals
        • Diagnostic Centers
        • Clinics
        • Government Organizations
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Becton Dickinson & Company *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Cepheid, Inc.
    • Abbott Laboratories
    • BioMerieux SA
    • Hologic, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • Roche Diagnostics
    • DiaSorin S.p.A.
    • Quidel Corporation
    • Bio-Rad Laboratories, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technique
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Infectious Disease Diagnostics Market, By Technique, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • ELISA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Polymerase Chain Reaction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Immunoassays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Cell Cultures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Infectious Disease Diagnostics Market, By Disease Indications, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • CNS Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Meningitis
        • Brain Abscess
    • Diarrheal Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Shigellosis
        • Cholera
        • Enteric/Typhoid Fever
    • Respiratory Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Tuberculosis
        • Influenza
        • Bronchitis
    • Blood Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Malaria
        • Dengue
        • Infectious Mononucleosis
        • Others
    • STDs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Chlamydia
        • AIDS
        • Syphilis
        • Others
  6. Global Infectious Disease Diagnostics Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Government Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Infectious Disease Diagnostics Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Becton Dickinson & Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cepheid, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BioMerieux SA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Hologic, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Roche Diagnostics
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • DiaSorin S.p.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Quidel Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 42 figures on “Infectious Disease Diagnostics Market – Global forecast to 2027.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo